Log in to save to my catalogue

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8942856

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

About this item

Full title

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2022-03, Vol.603 (7902), p.706-714

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The SARS-CoV-2 Omicron BA.1 variant emerged in 2021
1
and has multiple mutations in its spike protein
2
. Here we show that the spike protein of Omicron has a higher affinity for ACE2 compared with Delta, and a marked change in its antigenicity increases Omicron’s evasion of therapeutic monoclonal and vaccine-elicited polyclonal neutral...

Alternative Titles

Full title

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8942856

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8942856

Other Identifiers

ISSN

0028-0836,1476-4687

E-ISSN

1476-4687

DOI

10.1038/s41586-022-04474-x

How to access this item